Victory Capital Management
SCMP

Victory Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Victory Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,017
Closed -$33K – 1874
2016
Q2 		$33K Buy
3,017
+1,313
+77% +$14.7K ﹤0.01% 1571
2016
Q1 		$19K Buy
1,704
+349
+26% +$4.41K ﹤0.01% 1618
2015
Q4 		$23K Sell
1,355
-37
-3% -$663 ﹤0.01% 1634
2015
Q3 		$28K Sell
1,392
-1,098
-44% -$25.2K ﹤0.01% 1571
2015
Q2 		$42K Buy
+2,490
New +$43.2K ﹤0.01% 1541

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Victory Capital Management's SCMP Position: Q3 2016 in Review

Victory Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 3,017 shares — an estimated $33K sold.

Victory Capital Management first reported a position in SCMP in Q2 2015 and held it in 5 quarters. The position peaked at $42K in Q2 2015. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Victory Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Victory Capital Management sold 3,017 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $33K.
  • Victory Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • Victory Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $42K in Q2 2015.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Victory Capital Management's 13F filing for Q3 2016, filed 3 Nov 2016.